HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TALC INHALATION CARCINOGENICITY ISSUE MAY NEED MORE STUDY

This article was originally published in The Rose Sheet

Executive Summary

TALC INHALATION CARCINOGENICITY ISSUE MAY NEED MORE STUDY, FDA Office of Cosmetics and Colors Acting Director John Bailey, PhD, said at a recent workshop on talc safety cosponsored by FDA and the International Society of Regulatory Toxicology and Pharmacology. "It sounds as if we're leaning in the direction of needing more studies," Bailey said, following a discussion of inhalation data on the ingredient. The workshop was held Jan. 31 and Feb. 1 at the National Institutes of Health campus in Bethesda, MD.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000133

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel